OTC Watch

All stocks / RVRC

Revium Rx. RVRC

Revium Rx (RVRC): a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Late filingEstimated float OTCIDIsrael
Live quote on OTC Markets

Market listing

Full name
REVIUM RECOVERY INC
Market tier
OTC Pink Current
Trading status
Active
Last trade
Nov 11
Website
www.revolutionresourcescorp.com/
Source: Stockwatch, 2026-11-17

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Net loss
($13,449,000)
What it means

It spends more than it earns

Under strain

The company lost $13.4 million in the year. It reported no sales.

The report says
Total assets
$8,296,000
Total liabilities
$1,415,000
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $8.3 million. Its debts and unpaid bills add up to $1.4 million. That is about $0.17 owed for every $1 owned.

What this adds up to

1 of 2 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.

Signals

Late filing2026-11-16

Filed NT 10-Q on 2026-11-16: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Estimated float2026-08-13

Estimated float about 60,729,100 shares as of 2026-08-13: 60,729,100 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2024-12-31
60.7M
2025-12-31
60.7M
2026-03-30
61.3M
2026-03-31
60.7M
2026-05-13
60.7M
2026-06-30
60.7M
2026-08-13
60.7M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 NT 10-QNOTIFICATION OF LATE FILING
2026-08-13 10-QQUARTERLY REPORT
2026-06-22 8-KCURRENT REPORT
2026-06-01 8-KCURRENT REPORT
2026-05-14 10-QQUARTERLY REPORT
2026-04-20 8-KCURRENT REPORT
2026-03-31 10-KANNUAL REPORT
2026-01-30 EFFECT
2026-01-28 S-1/AAMENDMENT NO. 5 TO FORM S-1
2026-01-16 S-1/AAMENDMENT NO. 4 TO FORM S-1
2025-12-12 S-1/AAMENDMENT NO. 3 TO FORM S-1

Common questions about RVRC

Does RVRC file reports with the SEC?

Yes. Revium Rx files with the SEC under company number 0001839140. The most recent filing we hold is a NT 10-Q dated 2026-11-16.

Source record

How many RVRC shares are outstanding?

60,729,100 shares as of 2026-08-13, as reported to the SEC.

Source record

Has RVRC filed reports late?

Yes. In the last 12 months it filed 1 late-filing notice, most recently a NT 10-Q on 2026-11-16. A notice means a report was not ready on time; check whether the report followed.

Source record

Is Revium Rx making money?

The company lost $13.4 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record